Literature DB >> 24508030

Hypoxia and hypoxia inducible factors in tumor metabolism.

Wen Zeng1, Peiyi Liu2, Weimin Pan3, Shree Ram Singh4, Yiyong Wei5.   

Abstract

Because of the abnormal vasculature, most growing solid tumors contain regions that experience either acute or chronic hypoxia. However, tumor cells can maintain a high glycolytic rate even when there is enough oxygen supply. Hypoxia-inducible factors (HIFs) play crucial role in the response of tumor cells to this distinct microenvironment by shifting energy production from mitochondria towards glycolysis. In this review, we focus on the metabolism of tumor cell survival in hypoxic microenvironments. Furthermore, we also emphasize the mechanisms by which hypoxia and HIFs regulate tumor metabolism. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Apoptosis; HIFs; Hypoxia; Metabolism; Tumor; Tumor microenvironment

Mesh:

Substances:

Year:  2014        PMID: 24508030     DOI: 10.1016/j.canlet.2014.01.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  40 in total

1.  Something in the air: hyperoxic conditioning of the tumor microenvironment for enhanced immunotherapy.

Authors:  Robert D Leone; Maureen R Horton; Jonathan D Powell
Journal:  Cancer Cell       Date:  2015-04-13       Impact factor: 31.743

2.  A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances.

Authors:  Peng Liu; Yanbin Zhou; Xinyi Shi; Yu Yuan; Ying Peng; Surong Hua; Qiange Luo; Jinsong Ding; Yong Li; Wenhu Zhou
Journal:  J Nanobiotechnology       Date:  2021-05-21       Impact factor: 10.435

3.  Correlation and expression analysis of hypoxia-inducible factor 1α, glucose transporter 1 and lactate dehydrogenase 5 in human gastric cancer.

Authors:  Lang-Song Hao; Qi Liu; Chuan Tian; Dong-Xing Zhang; Bo Wang; Dong-Xu Zhou; Zhao-Peng Li; Zhi-Xiang Yuan
Journal:  Oncol Lett       Date:  2019-06-07       Impact factor: 2.967

4.  Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.

Authors:  J Li; Q Huang; X Long; X Guo; X Sun; X Jin; Z Li; T Ren; P Yuan; X Huang; H Zhang; J Xing
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

5.  Fluorescence quenching of free and bound NADH in HeLa cells determined by hyperspectral imaging and unmixing of cell autofluorescence.

Authors:  Aziz Ul Rehman; Ayad G Anwer; Martin E Gosnell; Saabah B Mahbub; Guozhen Liu; Ewa M Goldys
Journal:  Biomed Opt Express       Date:  2017-02-10       Impact factor: 3.732

6.  ADAR1 promotes robust hypoxia signaling via distinct regulation of multiple HIF-1α-inhibiting factors.

Authors:  Chung-Pei Ma; Hsuan Liu; Ian Yi-Feng Chang; Wan-Cheng Wang; Yi-Tung Chen; Shao-Min Wu; Hui-Wen Chen; Yu-Ping Kuo; Chieh-Tien Shih; Chuan-Yun Li; Bertrand Chin-Ming Tan
Journal:  EMBO Rep       Date:  2019-04-04       Impact factor: 8.807

7.  DEC1 is required for anti-apoptotic activity of gastric cancer cells under hypoxia by promoting Survivin expression.

Authors:  Yanfei Jia; Rui Hu; Ping Li; Yan Zheng; Yunshan Wang; Xiaoli Ma
Journal:  Gastric Cancer       Date:  2017-12-04       Impact factor: 7.370

8.  Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and related clinical significance.

Authors:  Rana Ezzeddini; Mohammad Taghikhani; Amir Salek Farrokhi; Mohammad Hossein Somi; Nasser Samadi; Ali Esfahani; Mohammad Javad Rasaee
Journal:  J Physiol Biochem       Date:  2021-03-17       Impact factor: 4.158

9.  Hypoxia-inducible factor-1α mediates the toll-like receptor 4 signaling pathway leading to anti-tumor effects in human hepatocellular carcinoma cells under hypoxic conditions.

Authors:  Xiaoyu Zhang; Shuchen Li; Mingrong Li; Haiying Huang; Jingyuan Li; Changwei Zhou
Journal:  Oncol Lett       Date:  2016-06-13       Impact factor: 2.967

10.  The Promoting Effect of Radiation on Glucose Metabolism in Breast Cancer Cells under the Treatment of Cobalt Chloride.

Authors:  Chun-Bo Zhao; Lei Shi; Hai-Hong Pu; Qing-Yuan Zhang
Journal:  Pathol Oncol Res       Date:  2016-06-24       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.